Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GW.5.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GW.5.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GW.5.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GW.5.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GW.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KC.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
KC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.13.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.13.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.13.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.13.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.13.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.13.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.13.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JY.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JY.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JY.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JY.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JY.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JY.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XCREWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCRECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCRECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCREHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCREHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCRENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCRENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.86EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.86ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.86ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.86EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.86EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.86ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GJ.1.2.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GJ.1.2.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used